Hadassah

Clinical Trial Begins at Hadassah University Medical Center with New Drug to Treat Stroke

Monday, Oct 24 2011

Clinical Trial Begins at Hadassah University Medical Center with New Drug To Treat Stroke. A Phase IIa clinical trial with a medicine to treat ischemic stroke has begun at the Hadassah University Medical Center, based on the research of Prof. Abd Al-Roof Higazi, head of the Department of Clinical Biochemistry at Hadassah Hospital Ein-Kerem.

The safety and clinical effectiveness of THR-18, a product of Thrombotech, will be tested on patients with ischemic stroke in seven medical centers throughout Europe, India, and Israel. Thrombotech Technologies Ltd. is a Portfolio Company of Clal Biotechnology Industries Ltd., Israel's largest active life sciences investment company, and Hadasit Bio-Holdings Ltd., a publicly traded subsidiary of Hadasit, Hadassah's technology transfer company, with biotech products all based on intellectual property developed and owned by the Hadassah University Medical Center.

Approximately 25 patients will be divided into three groups. One group will receive the currently used medication for treating ischemic stroke--tPA--and the other two groups will be treated with THR-18, in two different doses, in combination with tPA. Plans are for an evaluation of the trial to be completed within a year.

Related Stories

alt_text

Thursday, Mar 26 2020

Get the facts: Listen to Our "Understanding Coronavirus" Conference Call

Hadassah member and pediatric infectious disease specialist Dr. Jo-Ann Harris separates fact from fiction and answers questions from Hadassah members.

READ MORE ›
alt_text

Thursday, Mar 26 2020

Hadassah Nurse Cuts Short Maternity Leave to Work in Coronavirus Unit

After Hadassah nurse Moran Hanuka had baby number four in December, she was looking forward to extending her maternity leave...

READ MORE ›
alt_text

Thursday, Mar 26 2020

Hadassah to Supply 700,000 Bottles of Hadassol to Israeli Health System

Given Israel’s shortage of alcohol-based cleansing gel, the Hadassah Medical Organization has expanded production of Hadassol...

READ MORE ›
alt_text

Wednesday, Mar 25 2020

All-Staff Corona Testing at Hadassah Identifies Asymptomatic Carriers

As a result of the Hadassah Medical Organization’s decision to test all staff members at both Hadassah Hospital Ein Kerem and Hadassah Mount Scopus...

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Israel Travel

israeltravel@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More